Brief: Mineralys Announces Late-Breaking Presentation Of Phase 3 Launch-HTN Trial
20/05/2025 13:16
May 20 (Reuters) - Mineralys Therapeutics Inc MLYS.O: MINERALYS ANNOUNCES LATE-BREAKING PRESENTATION OF PHASE 3 LAUNCH-HTN TRIAL AT 34TH EUROPEAN MEETING ON HYPERTENSION AND CARDIOVASCULAR PROTECTION Source text: ID:nGNX4N2QPR Further company coverage: MLYS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mineralys Therapeutics
See all newsBrief: Mineralys Therapeutics Expands Its Board Of Directors With The Appointments Of Kristine Peterson And Lonnel Coats
Mineralys Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway